Stuart Ralston

Has grant

Professor of Rheumatology

University of Edinburgh

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stuart Ralston is a Professor of Rheumatology at Edinburgh University in the UK. His research primarily focuses on osteoporosis, Paget’s disease of bone, and the impact of immunosuppressive therapy on patients with inflammatory rheumatic diseases. Recent publications highlight the management and outcomes of these conditions, as well as innovative treatments such as pharmacotherapeutic approaches to mitigate fracture risk in at-risk populations.

Recent Grants

Grant: Close

Advancing knowledge to improve outcome in Paget’s disease of bone

Open Date: 2018-08-01

Close Date: 2025-07-31

Grant: Close

Randomised trial of Teriparatide followed by Zoledronic acid versus standard care to prevent fractures in adults with Osteogenesis Imperfecta

Open Date: 2016-11-01

Close Date: 2023-04-30

Grant: Close

Predicting therapeutic response to teriparatide therapy in osteoporosis by genetic profiling

Open Date: 2015-01-01

Close Date:

Grant: Close

Genetic and Environmental Determinants of Paget's Disease

Open Date: 2012-08-01

Close Date: 2015-07-31

Grant: Close

Effect of bisphosphonate therapy on healing and clinical outcome of wrist fractures: randomised controlled trial

Open Date: 2011-02-01

Close Date: 2016-01-31

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (12)

Peter Kamenický

Université Paris-Saclay

FRANCE

View details

Matthew Hilton

Associate Professor

Duke University

UNITED STATES

View details

Luis Corral-Gudino

Profesor contratado doctor vinculado fijo

Universidad de Valladolid

SPAIN

View details

Teresa Tarrant

Duke University

UNITED STATES

View details

Rosemary Hollick

University of Aberdeen

UNITED KINGDOM

View details

Jessica L. Bowser

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Bente Lomholt Langdahl

Aarhus University

DENMARK

View details

Nerea Alonso

Assistant Professor

Medical University of Graz

AUSTRIA

View details

Amanda Eudy

Assistant Professor

Duke University School of Medicine

UNITED STATES

View details

Zoe Paskins

UNITED KINGDOM

View details

David A McAllister

University of Glasgow

UNITED KINGDOM

View details

Rachel Crowley

St. Vincent's University Hospital

IRELAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stuart Ralston

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (18)

Continuous decline in Paget’s disease of bone: a One Health perspective on 2342 new diagnoses and their association with rural livestock

Height loss, back pain and severe pain are highly predictive of pregnancy associated osteoporosis

Response to: Correspondence on ‘Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures’ by Dai et al

Management of a Patient with Severe Osteogenesis Imperfecta Undergoing Laparoscopic Cholecystectomy

Methotrexate continuation increases fracture risk in patients who sustained lower limb insufficiency fractures

Prophylactic zoledronic acid therapy to prevent or modify Paget’s disease of bone progression in adults with SQSTM1 mutations: the ZiPP RCT

Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget’s Disease of Bone

Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta

Clinical Features, Incidence and Treatment Outcome in Pregnancy-Associated Osteoporosis: A Single-Centre Experience over Two Decades

Effective Communication and the Osteoporosis Care Gap

Probiotics Inhibit Cartilage Damage and Progression of Osteoarthritis in Mice

Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis

Insertion Mutation in Tnfrsf11a Causes a Paget's Disease-Like Phenotype in Heterozygous Mice and Osteopetrosis in Homozygous Mice.

Diagnosis and Management of Osteoporosis During COVID-19: Systematic Review and Practical Guidance

Correction to: Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation

Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone Formation

Collaborators (12)

Peter Kamenický

Matthew Hilton

Luis Corral-Gudino

Teresa Tarrant

Rosemary Hollick

Jessica L. Bowser

Bente Lomholt Langdahl

Nerea Alonso

Amanda Eudy

Zoe Paskins

David A McAllister

Rachel Crowley

Make your next move.